Funding for this research was provided by:
Ministero della Salute (5x1000 Funds – 2015 - ID code D171CB)
Received: 9 January 2020
Accepted: 20 July 2020
First Online: 28 July 2020
Ethics approval and consent to participate
: The project protocol was registered on ExternalRef removed (Identifier: NCT03968718, URL: ExternalRef removed) and approved by the Institutional review board (INT 167/18). Written informed consent to participate will be registered for all enrolled patients.
: Not applicable.
: Dr. Caraceni reports personal fees from Kyowa Kirin; Shionogi & Molteni; Angelini; Institute de recherche “Pierre Fabre”; Sandoz International GmbH; Italfarmaco; Pfizer; Molteni & soc. esercizio SpA; Helsin Healthcare; Gruenenthal GmbH, and grants from Molteni & C Soc Esercizio Spa; Prokstrakan; Gruenenthal GmbH; Amgen; Ipsen, outside the submitted work.All other authors declare that they have no competing interests.